170 related articles for article (PubMed ID: 11502857)
41. Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo.
Ben Ahmed M; Zaraa I; Rekik R; Elbeldi-Ferchiou A; Kourda N; Belhadj Hmida N; Abdeladhim M; Karoui O; Ben Osman A; Mokni M; Louzir H
Pigment Cell Melanoma Res; 2012 Jan; 25(1):99-109. PubMed ID: 21985183
[TBL] [Abstract][Full Text] [Related]
42. Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo.
Tulic MK; Cavazza E; Cheli Y; Jacquel A; Luci C; Cardot-Leccia N; Hadhiri-Bzioueche H; Abbe P; Gesson M; Sormani L; Regazzetti C; Beranger GE; Lereverend C; Pons C; Khemis A; Ballotti R; Bertolotto C; Rocchi S; Passeron T
Nat Commun; 2019 May; 10(1):2178. PubMed ID: 31097717
[TBL] [Abstract][Full Text] [Related]
43. Melanoma and Vitiligo: In Good Company.
Failla CM; Carbone ML; Fortes C; Pagnanelli G; D'Atri S
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731645
[TBL] [Abstract][Full Text] [Related]
44. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
[TBL] [Abstract][Full Text] [Related]
45. Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.
Gregg RK; Nichols L; Chen Y; Lu B; Engelhard VH
J Immunol; 2010 Feb; 184(4):1909-17. PubMed ID: 20083666
[TBL] [Abstract][Full Text] [Related]
46. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?
Gauthier Y; Cario Andre M; Taïeb A
Pigment Cell Res; 2003 Aug; 16(4):322-32. PubMed ID: 12859615
[TBL] [Abstract][Full Text] [Related]
47. [Humoral and cellular autoimmunity in genuine vitiligo studied by means of an antigen produced from melanoma cells].
Höfs T
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):244-50. PubMed ID: 6179826
[TBL] [Abstract][Full Text] [Related]
48. The Role of the NKG2D in Vitiligo.
Plaza-Rojas L; Guevara-Patiño JA
Front Immunol; 2021; 12():624131. PubMed ID: 33717132
[TBL] [Abstract][Full Text] [Related]
49. New insights into immune mechanisms of vitiligo.
Boniface K; Taïeb A; Seneschal J
G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
[TBL] [Abstract][Full Text] [Related]
50. Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo.
Yang L; Wei Y; Sun Y; Shi W; Yang J; Zhu L; Li M
Acta Derm Venereol; 2015 Jul; 95(6):664-70. PubMed ID: 25721262
[TBL] [Abstract][Full Text] [Related]
51. Experimental approaches to assess melanocytes mosaicism in segmental vitiligo.
Dellatorre G; Fava VM; Mira MT; Silva de Castro CC
An Bras Dermatol; 2023; 98(2):216-220. PubMed ID: 36529602
[TBL] [Abstract][Full Text] [Related]
52. Integrating neuronal involvement into the immune and genetic paradigm of vitiligo.
Al Abadie MS; Gawkrodger DJ
Clin Exp Dermatol; 2021 Jun; 46(4):646-650. PubMed ID: 33098692
[TBL] [Abstract][Full Text] [Related]
53. Antibodies to normal human melanocytes in vitiligo.
Naughton GK; Eisinger M; Bystryn JC
J Exp Med; 1983 Jul; 158(1):246-51. PubMed ID: 6345714
[TBL] [Abstract][Full Text] [Related]
54. The genetics of vitiligo.
Spritz RA
J Invest Dermatol; 2011 Nov; 131(E1):E18-20. PubMed ID: 22094401
[No Abstract] [Full Text] [Related]
55. Autoimmune etiology of generalized vitiligo.
Le Poole IC; Luiten RM
Curr Dir Autoimmun; 2008; 10():227-43. PubMed ID: 18460889
[TBL] [Abstract][Full Text] [Related]
56. Vitiligo and polyglandular autoimmune disease with autoantibodies to melanin-producing cells. A new syndrome?
Peserico A; Rigon F; Semenzato G; Caretto A; Pasini CV; Betterle C
Arch Dermatol; 1981 Nov; 117(11):751-2. PubMed ID: 7316541
[No Abstract] [Full Text] [Related]
57. Dilated rough endoplasmic reticulum and premature death in melanocytes cultured from the vitiligo mouse.
Boissy RE; Beato KE; Nordlund JJ
Am J Pathol; 1991 Jun; 138(6):1511-25. PubMed ID: 2053597
[TBL] [Abstract][Full Text] [Related]
58. Understanding mechanisms of vitiligo development in Smyth line of chickens by transcriptomic microarray analysis of evolving autoimmune lesions.
Shi F; Kong BW; Song JJ; Lee JY; Dienglewicz RL; Erf GF
BMC Immunol; 2012 Apr; 13():18. PubMed ID: 22500953
[TBL] [Abstract][Full Text] [Related]
59. Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected?
Namazi MR
Pigment Cell Res; 2007 Oct; 20(5):360-3. PubMed ID: 17850509
[TBL] [Abstract][Full Text] [Related]
60. Vitiligo.
Sharquie KE
Clin Exp Dermatol; 1984 Mar; 9(2):117-26. PubMed ID: 6370515
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
